Brian Olsavsky
Director of Finance/CFO chez AMAZON.COM, INC.
Fortune : 9 M $ au 29/02/2024
Profil
Brian T. Olsavsky occupe le poste de directeur financier et vice-président senior d'Amazon.com, Inc. Dans le passé, il a occupé le poste de vice-président adjoint chez Deutsche Morgan Grenfell. M. Olsavsky a obtenu un diplôme de premier cycle de l'Université d'État de Pennsylvanie et un MBA de l'Université Carnegie Mellon.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
AMAZON.COM, INC.
0,00% | 21/02/2024 | 50 527 ( 0,00% ) | 9 M $ | 29/02/2024 |
Postes actifs de Brian Olsavsky
Sociétés | Poste | Début |
---|---|---|
AMAZON.COM, INC. | Director of Finance/CFO | 01/06/2015 |
Anciens postes connus de Brian Olsavsky
Sociétés | Poste | Fin |
---|---|---|
Deutsche Morgan Grenfell | Corporate Officer/Principal | - |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Director/Board Member | - |
Formation de Brian Olsavsky
Carnegie Mellon University | Masters Business Admin |
The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMAZON.COM, INC. | Retail Trade |
Entreprise privées | 2 |
---|---|
Deutsche Morgan Grenfell | Finance |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |